Logo image of ABP

ABPRO HOLDINGS INC (ABP) Stock Overview

NASDAQ:ABP - US0008471031 - Common Stock

0.2451 USD
+0 (+0.57%)
Last: 8/29/2025, 8:05:07 PM
0.2499 USD
+0 (+1.96%)
After Hours: 8/29/2025, 8:05:07 PM

ABP Key Statistics, Chart & Performance

Key Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap19.65M
Shares80.17M
Float0
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.87
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO01-14 2022-01-14
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


ABP short term performance overview.The bars show the price performance of ABP in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40

ABP long term performance overview.The bars show the price performance of ABP in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of ABP is 0.2451 USD. In the past month the price increased by 2.94%.

ABPRO HOLDINGS INC / ABP Daily stock chart

ABP Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 19.87 371.68B
AMGN AMGEN INC 13.19 154.89B
GILD GILEAD SCIENCES INC 14.6 140.17B
VRTX VERTEX PHARMACEUTICALS INC 23.08 100.25B
REGN REGENERON PHARMACEUTICALS 12.72 61.55B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 58.53B
ARGX ARGENX SE - ADR 76.83 43.59B
ONC BEONE MEDICINES LTD-ADR 6.16 36.38B
INSM INSMED INC N/A 28.77B
BNTX BIONTECH SE-ADR N/A 24.04B
NTRA NATERA INC N/A 23.09B
BIIB BIOGEN INC 8.26 19.38B

About ABP

Company Profile

ABP logo image Abpro Holdings, Inc. operates as a capital pool company. The company is headquartered in New York City, New York and currently employs 6 full-time employees. The company went IPO on 2022-01-14. The firm is advancing a pipeline of next generation antibody therapies for human epidermal growth factor receptor 2 (HER2)+cancers, non-HER2+ gastric and liver cancer, and wet age-related macular degeneration and diabetic macular edema. These antibodies are developed using the Company’s proprietary DiversImmune platform. Its two lead product candidates, ABP-102 and ABP-201, feature its next generation tetravalent antibody format (TetraBi antibody format), which binds to two different targets with two distinct binding sites per target. ABP-102 is designed to redirect a patient’s immune system to fight cancer by engaging T cells through co-targeting HER2, and CD3, T-cell co-receptor. ABP-201 is designed to block blood vessel formation and normalize damaged vessels through co-targeting VEGF and ANG-2. The company plans to develop ABP-201 to treat vascular disease of the eye, focusing on wet age-related macular degeneration (Wet AMD).

Company Info

ABPRO HOLDINGS INC

6 St Johns Lane, Floor 5

New York City NEW YORK US

Employees: 6

ABP Company Website

Phone: 12488907200

ABPRO HOLDINGS INC / ABP FAQ

What is the stock price of ABPRO HOLDINGS INC today?

The current stock price of ABP is 0.2451 USD. The price increased by 0.57% in the last trading session.


What is the ticker symbol for ABPRO HOLDINGS INC stock?

The exchange symbol of ABPRO HOLDINGS INC is ABP and it is listed on the Nasdaq exchange.


On which exchange is ABP stock listed?

ABP stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ABPRO HOLDINGS INC stock?

5 analysts have analysed ABP and the average price target is 2.04 USD. This implies a price increase of 732.31% is expected in the next year compared to the current price of 0.2451. Check the ABPRO HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ABPRO HOLDINGS INC worth?

ABPRO HOLDINGS INC (ABP) has a market capitalization of 19.65M USD. This makes ABP a Nano Cap stock.


How many employees does ABPRO HOLDINGS INC have?

ABPRO HOLDINGS INC (ABP) currently has 6 employees.


What are the support and resistance levels for ABPRO HOLDINGS INC (ABP) stock?

ABPRO HOLDINGS INC (ABP) has a support level at 0.24 and a resistance level at 0.25. Check the full technical report for a detailed analysis of ABP support and resistance levels.


Should I buy ABPRO HOLDINGS INC (ABP) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ABPRO HOLDINGS INC (ABP) stock pay dividends?

ABP does not pay a dividend.


What is the Price/Earnings (PE) ratio of ABPRO HOLDINGS INC (ABP)?

ABPRO HOLDINGS INC (ABP) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.87).


ABP Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to ABP.


Chartmill TA Rating
Chartmill Setup Rating

ABP Financial Highlights

Over the last trailing twelve months ABP reported a non-GAAP Earnings per Share(EPS) of -0.87. The EPS decreased by -2966.01% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -396%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-776.85%
Sales Q2Q%-100%
EPS 1Y (TTM)-2966.01%
Revenue 1Y (TTM)289.36%

ABP Forecast & Estimates

5 analysts have analysed ABP and the average price target is 2.04 USD. This implies a price increase of 732.31% is expected in the next year compared to the current price of 0.2451.


Analysts
Analysts80
Price Target2.04 (732.31%)
EPS Next Y0%
Revenue Next YearN/A

ABP Ownership

Ownership
Inst Owners7.1%
Ins Owners3.06%
Short Float %N/A
Short Ratio0.36